SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001017491-17-000074
Filing Date
2017-05-11
Accepted
2017-05-11 16:02:31
Documents
56
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q apri3311710q.htm 10-Q 933985
2 EXHIBIT 31.1 apri33117ex311.htm EX-31.1 11893
3 EXHIBIT 32.1 apri33117ex321.htm EX-32.1 5890
  Complete submission text file 0001017491-17-000074.txt   5192642

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT apri-20170331.xml EX-101.INS 828122
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apri-20170331.xsd EX-101.SCH 48071
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT apri-20170331_cal.xml EX-101.CAL 72558
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apri-20170331_def.xml EX-101.DEF 255444
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apri-20170331_lab.xml EX-101.LAB 601384
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apri-20170331_pre.xml EX-101.PRE 393625
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22245 | Film No.: 17834203
SIC: 2834 Pharmaceutical Preparations